Prezentace aplikace PowerPoint - FN Nano Inc. Photocatalytic

Report
Superior Performance of FN® Coatings
(photocatalytic multifunctional nano coatings)
MEDICAL APPLICATIONS
FN® Coatings
Apply in …
And say „no more“ to …
• Living rooms, bedrooms,
kids rooms
• Kitchens and bathrooms
• Hotels, spas, restaurants
and cafeterias
• Schools and nurseries
• Hospitals and clinics
• Offices and public areas
• Headaches, lethargy, fatigue,
and poor concentration
• Respiratory illnesses and
asthmas
• Allergies and skin irritations
• Virus and bacteria dispersion
• Unpleasant odors, molds and
dirt on walls
WHY FN® COATINGS IN HOSPITALS
AND MEDICAL FACILITIES?
PATIENT AND PERSONNEL
NOSOCOMIAL
INFECTIONSPROTECTION
MRSA
SANITARY
AND CLEAN ENVIRONMENT
INFECTIONS OUTBREAKS
OUTBREAK CONTROL
OVEREXPOSURE
FAST REMOVAL OF
TO EXCESS OF
DISINFECTIONS
DISINFECTION AND
AND
CHEMICALS
CHEMICALS
INFECTION OUTBREAK
FN® COATING
INFECTION OUTBREAK CONTROL
SOFT UVA ACTIVATION LIGHTS ON!!!
THE AIR IS CLEAN IN ABOUT 1-2 HOURS
• VIRUS CONCENTRATION STABILIZED UNDER
THE INFECTION CRITICAL LEVEL
• INFECTION LOCALIZED
FN2
Non active
15 min
FN2
Non active
30 min
FN® ANTIMICROBIAL FUNCTION
WAS PROVEN BY SEVERAL
ACCREDITED LABS AND IN MANY
PRACTICAL APPLICATIONS
PUBLIC HEALTH PROTECTION
VERY EFFICIENT NON-CHEMICAL SANITARY FUNCTION
Microorganism
UV
UV
Exposure Intensity
time (min) mW/cm2
Bakteriofag E.Coli ΦX 174 60 min
(MODEL VIRUS)
60 min
6 hours
6 hours
6 hours
6 hours
60 min
Candida albicans
Candida albicans
120 min
120 min
Pseudomonas aeruginosa 120 min
Pseudomonas aeruginosa 120 min
START
Reference sample
END
END
concentration
concentration
(CFU)
(CFU)
BACTERIA
REDUCTION ON
FN2 SURFACE
(%)
1.00E+06
1.00E+06
1.00E+08
1.00E+05
1.00E+08
1.00E+05
1.00E+06
99.9940%
99.9970%
99.9999%
100%
99.9996%
99.9850%
0%
1.00E+06
1.00E+06
100%
100%
100%
100%
99.99949%
• HOSPITALS
concentration
• MEDICAL(CFU)
CENTERS
0.2 ml
•0.05-0.1
BIOLABS
1.00E+06
60
1.00E+06
30
•0.05-0.1
OFFICES
0.05-0.1
1.00E+08
88
1.00E+05
0
•0.05-0.1
SCHOOLS
1.00E+08
400
•0.05-0.1
KINDERGARTENS
0.05-0.1
1.00E+05
15
1.00E+06
•0-darkBANKS1.00E+06
0.2 ml
•0.05-0.1
PUBLIC1.00E+06
BUILDINGS0
1.00E+06 STATIONS
0
•0.05-0.1
TRAIN/BUS
0.2 ml
•0.05-0.1
AIRPORTS
1.00E+06
0
0.05-0.1
1.00E+06
0
1.00E+06
1.00E+06
1.50E+08
767
not countable
0.3 ml
Enterococcus faecalis 4224 120 min
0.1-0.3
Candida albicans
Pseudomonas
aeruginosa
Enterococcus
faecalis
E. faecalis can cause life-threatening
infections in humans, especially in
the nosocomial(hospital)
environment, where the naturally high
levels of antibiotic resistance found
in E. faecalis contribute to its
pathogenicity.[1] E. faecalis has been
frequently found in root canal-treated
teeth.
Image courtesy of http://www.chuv.ch/
UV
UV
Exposure Intensity
time (min) mW/cm2
Reference sample
END
END
concentration
concentration
(CFU)
(CFU)
BACTERIA
REDUCTION ON
FN2 SURFACE
(%)
START
Microorganism
concentration
(CFU)
Yeast fungi: Candida albicans can cause serious
Pseudomonas aeruginosa has become an important cause of
0.2 ml
and potentially life-threatening infections in the infection, especially in patients with compromised host defense
Bakteriofag E.Coli ΦX 174 60 min
0.05-0.1
1.00E+06
60
1.00E+06
99.9940%
mouth, blood and other tissues of people who
mechanisms. It is the most common pathogen isolated from
(MODEL VIRUS)
60 min
0.05-0.1
1.00E+06
30
1.00E+06
99.9970%
are undergoing cancer chemotherapy
or
patients who have been hospitalized longer than 1 week. It is a
6 hours
0.05-0.1
1.00E+08
88
1.00E+08
99.9999%
radiation treatments, or who
have developed
frequent
cause of nosocomial
infections
such as pneumonia,
6 hours
1.00E+05
0
1.00E+05
AIDS or other diseases that
damage 0.05-0.1
the
urinary
tract infections (UTIs),
and bacteremia.
Pseudomonal100%
6 hours
0.05-0.1
1.00E+08are complicated
400 and can be
1.00E+08
immunity of the individual.
infections
life threatening. 99.9996%
6 hours
0.05-0.1
1.00E+05
15
1.00E+05
99.9850%
60 min
0-dark
1.00E+06
1.00E+06
1.00E+06
0%
0.2 ml
Candida albicans
120 min 0.05-0.1
1.00E+06
0
1.00E+06
100%
Candida albicans
120 min 0.05-0.1
1.00E+06
0
1.00E+06
100%
0.2 ml
Pseudomonas aeruginosa 120 min 0.05-0.1
1.00E+06
0
1.00E+06
100%
Pseudomonas aeruginosa 120 min 0.05-0.1
1.00E+06
0
1.00E+06
100%
0.3 ml
Enterococcus faecalis 4224 120 min 0.1-0.3
1.50E+08
767
not countable
99.99949%
FN®:
•PROVIDES HELPFUL PROTECTION TO
CHILDREN AND OTHER PATIENTS ON
CHEMOTHERAPY
•PREVENTION OF INFFECTION OUTBREAKS
Microorganism
(FN2 Protocol #)
Stapthylococcus aureus CCM 3953
1734/2010 H4
1474/2010 P4
1470/2010 P3
1473/2010 H4
1472/2010 H3
FN2 A
FN2 B
FN2 C
Stapthylococcus aureus ATCC 33591
FN2-P1
FN2-P2
Staphylococcus aureus CCM 3953
prints on agar
Stapthylococus aureus
PP-FN2 tab 67
FN2 tab 61
FN2 DARK tab 42
START
END
Exposure UV UV Intensity concentration concentration
time (min)
mW/cm2
(CFU)
(CFU)
0.2 ml
60
0.05-0.1
1.20E+08
100
60
0.05-0.1
1.20E+08
150
60
0.05-0.1
1.20E+08
100
60
0.05-0.1
1.20E+08
100
60
0.05-0.1
1.30E+08
100
60
0.05-0.1
3.45E+07
250
60
0.05-0.1
3.45E+07
250
®
60
0.05-0.1
3.45E+07
250
Reference sample
END concentration
(CFU)
Bacteria reduction
on FN2 surface
(%)
7.50E+05
7.50E+05
7.50E+05
7.50E+05
7.50E+05
1.10E+06
1.10E+06
1.10E+06
99.9999%
99.9999%
99.9999%
99.9999%
99.9999%
99.9993%
99.9993%
99.9993%
NA
NA
100%
100%
LEGISLATION
INnotEU)
34
countable
99.99998%
FN :
0.35 ml
• BIOCIDIDE EFFICACY
80
NA
1.00E+05
0
•80 NO CHEMISTRY-PHYSICAL
EFFECT
NA
1.00E+05
0
(2011
120
120
300
120
REMOVED
0.1-0.3
0.05-0.1
0.05-0.1
dark
0.3 ml
FROM BIOCIDE
1.80E+08
0.1 ml
1.65E+09
1.00E+06
1.00E+06
34
250
1.00E+06
1.00E+04
1.00E+06
1.00E+06
99.999998%
99.975000%
0%
MRSA is a serious hospital acquired infection, which is a form of
the Staphylococcus bacterium resistant to the commonly used
antibiotic methicillin. http://www.direct-healthcare.com/mrsa.htm
FN Coatings are an excellent
prevention of MRSA.
No release of chemicals into
the environment!!!
Proportionally, 50% reduction of MRSA in
the USA means:
 Saving life to 12,500 people
 Saving post operation problems to
250,000 people
 Reduction of economical losses ~ $ 4bn
Hospital Acquired Infections cost
the NHS around £1bn per
annum, affect some 100,000
patients a year and is
responsible for the deaths of
around 5,000 patients annually
in the UK.
……. alarming rate with some
hospitals reporting secondary
infection rates as high as 20%.
FN® COATINGS – NO CHEMISTRY INVOLVED
 FN® COATINGS ARE EXTREMELY EFFICIENT IN “BURNING”
MICROORGANISMS ON THEIR HIGHLY OXIDATIVE SURFACE
 THE PHOTOCATALYTIC ACTION IS AS STRONG AS USING POISONOUS
CHEMICALS, WHILE IT IS PROVIDED SOLELY BY THE TiO2 PHYSICAL
EFFECT OF PHOTOCATALYSIS, WHITH NO CHEMISTRY INVOLVED
 TiO2 IS COMPLETELY INERT, SAFE AND UNREGULATED COMPOUND
 WALLS AND CEILING PAINTED BY FN® COATINGS ARE A GREAT
MICROBIAL PREVENTION AND A WAY, HOW TO CREATE CLEAN AND
SANITARY ENVIRONMENT WITHOUT ANY CHEMICALS INVOLVED
 FN® COATINGS ARE INERT AND PERFECTLY COMPACTIBLE WITH ALL
CHEMICALS AND DISINFECTING AGENTS.
PRACTICAL INSTALLATION DIFFERS ONLY
SLIGHTLY FROM REGULAR PAINTING
GIC
result
CEILINGS – FN3® COATING
UVA ACTIVATION LIGHT
WALLS– FN2® COATING
DAYLIGHT – MAIN SOURCE
OF THE ACTIVATION ENERGY
Internal Medicine Hospital
SOFT UVA ACTIVATION LAMPS INSTALLED FOR DARK DAYS,
NIGHT AND CRITICAL SITUATIONS SUCH AS INFECTION
OUTBREAKS, ODOR PROBLEMS, ETC,…
PHARMACY STORES
USEFUL UNIVERSALLY
Warehouses
Fitness
centers
Dental clinique
CHILDREN’S ONCOLOGY
WAITING
ROOMS
Eye Clinique
BREATH SAFE AIR
YESTERDAY
UNKNOWN
TODAY AN
OPTION
TOMORROW A
STANDARD

similar documents